Adoption of organ-on-chip platforms by the pharmaceutical industry

Nephrotoxic antisense oligonucleotide SPC5001 induces kidney injury biomarkers in a proximal tubule-on-a-chip

(2021) Tom T. G. Nieskens et al.   ARCHIVES OF TOXICOLOGY

Opportunities and challenges with microphysiological systems: a pharma end-user perspective

(2020) Lorna Ewart et al.   NATURE REVIEWS DRUG DISCOVERY

Organs-on-chips: into the next decade

(2020) Lucie A. Low et al.   NATURE REVIEWS DRUG DISCOVERY

Human Retinal Microvasculature‐on‐a‐Chip for Drug Discovery

(2020) Héloïse Ragelle et al.   Advanced Healthcare Materials

On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships

(2019) Christopher W. McAleer et al.   Scientific Reports

Reproducing human and cross-species drug toxicities using a Liver-Chip

(2019) Kyung-Jin Jang et al.   Science Translational Medicine

Organ-on-Chip Recapitulates Thrombosis Induced by an anti-CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems

(2018) Riccardo Barrile et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture model

(2018) Juliane Hübner et al.   Scientific Reports